Sharpley, A. L., Williams, C., Holder, A. A., Godlewska, B. R., Singh, N., Shanyinde, M., . . . Cowen, P. J. (2020). A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania. Psychopharmacology (Berl).
シカゴスタイル引用形Sharpley, Ann L., Clare Williams, Adele A. Holder, Beata R. Godlewska, Nisha Singh, Milensu Shanyinde, Orla MacDonald, , Philip J. Cowen. "A Phase 2a Randomised, Double-blind, Placebo-controlled, Parallel-group, Add-on Clinical Trial of Ebselen (SPI-1005) As a Novel Treatment for Mania or Hypomania." Psychopharmacology (Berl) 2020.
MLA引用形式Sharpley, Ann L., et al. "A Phase 2a Randomised, Double-blind, Placebo-controlled, Parallel-group, Add-on Clinical Trial of Ebselen (SPI-1005) As a Novel Treatment for Mania or Hypomania." Psychopharmacology (Berl) 2020.